We found that CXCL13 is overexpressed within breast cancer tissues at the mRNA and protein levels and that increased serum levels of this cytokine can be found in breast cancer patients with metastatic disease pointing to a possible role of CXCL13 within the development and progression of breast cancer. The gene discussed is CXCL13; the disease is breast carcinoma.